Medscape

• NCCN 2009: Guidelines for Ovarian Cancer Updated
  A host of changes in the treatment of ovarian cancer are described in these new guidelines, including the option to deliver chemotherapy intraperitoneally, which significantly improves survival.
  March 20, 2009
• NCCN 2009: Guidelines for Breast Cancer Updated
  The NCCN's breast cancer guidelines have a number of changes, including a recommendation for genetic counseling in some women and a ranking of adjuvant chemotherapies.
  March 19, 2009
• NCCN 2009: Recommendations About Testing for ER/PR in Breast Cancer Forthcoming
  An NCCN task force will recommend testing for estrogen and progesterone receptors in breast cancer, even though it acknowledges that there are problems with such testing.
  March 18, 2009
• NCCN 2009: Recommendations on Managing Skin Toxicities With EGFR Inhibitors
  Dermatologic toxicities related to cancer treatment with epidermal growth-factor-receptor inhibitors should be treated reactively. Changes in therapy should be avoided if possible because rash is associated with improved outcome.
  March 17, 2009
• NCCN 2009: Survival Increases as Drug Options Grow in Kidney Cancer
  As treatment options for kidney cancer have increased, survival has too. Patients with advanced disease need to be offered the new therapies.
  March 16, 2009

• National Comprehensive Cancer Network (NCCN) Breast Cancer Guideline, Version 1.2009 Developed by a panel of 28 multidisciplinary breast cancer experts from NCCN Member Institutions, these guidelines are designed to assist with evidence-based decision-making.
  February 2009
• National Comprehensive Cancer Network (NCCN) Non-Small Cell Lung Cancer Guideline, Version 2.2009Developed by a panel of 30 multidisciplinary lung cancer experts from NCCN Member Institutions, these guidelines are designed to assist with evidence-based decision-making.
  February 2009
• National Comprehensive Cancer Network (NCCN) Colon Cancer and Rectal Cancer Guidelines, Version 1.2009Developed by a panel of 28 multidisciplinary colon cancer and rectal cancer experts from NCCN Member Institutions, these guidelines are designed to assist with evidence-based decision-making.
  February 2009
• National Comprehensive Cancer Network (NCCN) Prostate Cancer Guideline, Version 1.2009Developed by a panel of 24 multidisciplinary prostate cancer experts from NCCN Member Institutions, these guidelines are designed to assist with evidence-based decision-making.
  February 2009

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.